Tilray | TRLY - Ebitda

股票价格

9.23

每天变化

-0.23 -2.43%

每月一次

-3.75%

每年

1,237.68%

Q2 预测

9.04

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 7.16B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	Ebitda	更改		日
Acasti Pharma	USD -2.45M		735K	2025-12
Akebia Therapeutics	USD 14.03M		17.19M	2025-03
Alaunos Therapeutics	USD -21.02M		1.33M	2021-03
Aurora Cannabis	CAD 18.48M		3.11M	2025-12
Avita Medical	AUD -9.69M		12.21M	2025-12
Canopy Growth	CAD -2.87M		19.49M	2025-12
Cronos Group	USD 456K		5.22M	2025-12
Dianthus Therapeutics	USD -40.19M		5.36M	2025-09
Divis Laboratories Ltd	INR 8.9B		20M	2025-12
Ionis Pharmaceuticals	USD -157.12M		307.36M	2025-09
IQVIA Holdings	USD 1.05B		97M	2025-12
Knight Therapeutics	CAD 24.45M		3.46M	2025-12
Moderna	USD -790M		582M	2025-12
Organigram Holdings	CAD 5.26M		884K	2025-12
Organon & Co	USD 383M		135M	2025-12
Revvity	USD 248.91M		48.52M	2025-12
Tectonic Therapeutic	USD -21.18M		365K	2025-12
Tilray	USD 8.36M		1.82M	2025-09
Viatris	USD 1B		151.5M	2025-12
Xeris Pharmaceuticals	USD 25.09M		7.67M	2025-12
Zealand Pharma A/S	-727.47M		285.54M	2025-12